FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1230051000168105: Methoblastin PFS (methotrexate 10 mg / 0.4 mL) injection, 0.4 mL syringe (trade product unit of use)

Status: current, Defined. Date: 30-Nov 2018. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
3149351000168113 Methoblastin PFS (methotrexate 10 mg / 0.4 mL) injection, 0.4 mL syringe (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
3149361000168110 Methoblastin PFS 10 mg/0.4 mL injection, 0.4 mL syringe en Synonym Active Case sensitive Australian Medicines Terminology module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Methoblastin PFS 10 mg/0.4 mL injection, 0.4 mL syringe Is a Methoblastin PFS true Inferred relationship Some
Methoblastin PFS 10 mg/0.4 mL injection, 0.4 mL syringe Is a methotrexate 10 mg/0.4 mL injection, syringe true Inferred relationship Some
Methoblastin PFS 10 mg/0.4 mL injection, 0.4 mL syringe Is a trade product unit of use true Inferred relationship Some
Methoblastin PFS 10 mg/0.4 mL injection, 0.4 mL syringe has manufactured dose form injection true Inferred relationship Some
Methoblastin PFS 10 mg/0.4 mL injection, 0.4 mL syringe has unit of use syringe true Inferred relationship Some 37322629
Methoblastin PFS 10 mg/0.4 mL injection, 0.4 mL syringe has Australian BoSS methotrexate true Inferred relationship Some 37322628
Methoblastin PFS 10 mg/0.4 mL injection, 0.4 mL syringe has intended active ingredient methotrexate true Inferred relationship Some 37322628
Inbound Relationships Type Active Source Characteristic Refinability Group
Methoblastin PFS 10 mg/0.4 mL injection, 12 x 0.4 mL syringes has TPUU True Methoblastin PFS 10 mg/0.4 mL injection, 0.4 mL syringe Inferred relationship Some 1
Methoblastin PFS 10 mg/0.4 mL injection, 4 x 0.4 mL syringes has TPUU True Methoblastin PFS 10 mg/0.4 mL injection, 0.4 mL syringe Inferred relationship Some 1
Methoblastin PFS 10 mg/0.4 mL injection, 0.4 mL syringe has TPUU True Methoblastin PFS 10 mg/0.4 mL injection, 0.4 mL syringe Inferred relationship Some 1
Methoblastin PFS 10 mg/0.4 mL injection, 12 x 0.4 mL syringes has TPUU True Methoblastin PFS 10 mg/0.4 mL injection, 0.4 mL syringe Inferred relationship Some 1
Methoblastin PFS 10 mg/0.4 mL injection, 4 x 0.4 mL syringes has TPUU True Methoblastin PFS 10 mg/0.4 mL injection, 0.4 mL syringe Inferred relationship Some 1
Methoblastin PFS 10 mg/0.4 mL injection, 24 x 0.4 mL syringes has TPUU True Methoblastin PFS 10 mg/0.4 mL injection, 0.4 mL syringe Inferred relationship Some 1
Methoblastin PFS 10 mg/0.4 mL injection, 6 x 0.4 mL syringes has TPUU True Methoblastin PFS 10 mg/0.4 mL injection, 0.4 mL syringe Inferred relationship Some 1
Methoblastin PFS 10 mg/0.4 mL injection, 24 x 0.4 mL syringes has TPUU True Methoblastin PFS 10 mg/0.4 mL injection, 0.4 mL syringe Inferred relationship Some 1
Methoblastin PFS 10 mg/0.4 mL injection, 6 x 0.4 mL syringes has TPUU True Methoblastin PFS 10 mg/0.4 mL injection, 0.4 mL syringe Inferred relationship Some 1
Methoblastin PFS 10 mg/0.4 mL injection, 0.4 mL syringe has TPUU True Methoblastin PFS 10 mg/0.4 mL injection, 0.4 mL syringe Inferred relationship Some 1

Reference Sets

Trade product unit of use reference set

Back to Start